FDA Approves Cangene Corporation (CC:CNJ)'s Treatment for Botulism
3/25/2013 7:46:07 AM
More...
|
Ipsen (IPN.PA) and Inspiration Biopharmaceuticals Announce Closing of the IB1001 Sale to Cangene Corporation (CC:CNJ)
2/20/2013 10:31:59 AM
More...
|
Celtic Pharma Welcomes the Results of the Sale Process of Inspiration Biopharmaceuticals' Hemophilia Assets to Cangene Corporation (CC:CNJ)
2/7/2013 9:47:32 AM
More...
|
Ipsen (IPN.PA) Sells Hemophilia B Drug to Cangene Corporation (CC:CNJ)
2/6/2013 7:15:48 AM
More...
|
Biotech Firm Cangene Corporation (CC:CNJ) Cuts 120 Jobs
1/6/2012 7:32:27 AM
More...
|
Cangene Corporation (CC:CNJ) Names John A. Sedor as President and Chief Executive Officer
8/17/2011 5:46:10 AM
More...
|
Biomedical Advanced Research and Development Authority (BARDA) Exercises Options With Cangene Corporation (CC:CNJ) Worth US$61 Million Under Botulism Antitoxin Supply Contract
6/6/2011 7:11:21 AM
More...
|
Cangene Corporation (CC:CNJ) Makes Organizational Changes In Canadian Operations; Cuts 40 Jobs
4/8/2011 1:40:16 PM
More...
|
Maxygen, Inc. (MAXY) Announces Expiration of Cangene Corporation (CC:CNJ)’s Option to License MAXY-G34 for Acute Radiation Syndrome
7/19/2010 9:19:17 AM
More...
|
Cangene Corporation (CC:CNJ) Announces Amendment to Normal Course Issuer Bid
11/12/2009 11:27:07 AM
More...
|
|